Showing results (11-20 of 137) with videos related to
Sort By:
Pageof 14
Exploration of Targeted Anti-Tumor Therapy|November 29, 2023
Integration of signaling pathway and bromodomain and extra-terminal domain inhibition for the treatment of mutant Kirsten rat sarcoma viral oncogene homolog cancerGerhard Hamilton, Sandra Stickler, Barbara RathCancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Non-small cell lung cancer-small cell lung cancer transformation as mechanism of resistance to tyrosine kinase inhibitors in lung cancerBarbara Rath, Adelina Plangger, Gerhard HamiltonCurrent Pharmaceutical Design|April 19, 2023
Targeting of SOS1: from SOS1 Activators to Proteolysis Targeting ChimerasGerhard Hamilton, Sandra Stickler, Barbara RathTranslational Lung Cancer Research|May 17, 2023
Significance of circulating tumor cells in lung cancer: a narrative reviewGerhard Hamilton, Barbara Rath, Sandra SticklerExpert Opinion on Drug Metabolism & Toxicology|March 4, 2015
Pharmacokinetics of crizotinib in NSCLC patientsGerhard Hamilton, Barbara Rath, Otto BurghuberJournal of Cancer|August 19, 2017
In vitro Cytotoxic Activities of the Oral Platinum(IV) Prodrug Oxoplatin and HSP90 Inhibitor Ganetespib against a Panel of Gastric Cancer Cell LinesLukas Klameth, Barbara Rath, Gerhard HamiltonTranslational Lung Cancer Research|July 25, 2015
Chitinase-3-like-1/YKL-40 as marker of circulating tumor cellsGerhard Hamilton, Barbara Rath, Otto BurghuberOncoscience|October 2, 2015
How to target small cell lung cancerGerhard Hamilton, Barbara Rath, Ernst UlspergerCurrent Cancer Drug Targets|January 26, 2024
Bromodomain Protein-directed Agents and MYC in Small Cell Lung CancerGerhard Hamilton, Sandra Stickler, Barbara RathOncology Research|April 30, 2024
Targeting KRAS in pancreatic cancerSandra Stickler, Barbara Rath, Gerhard HamiltonPageof 14